Browsing by Subject "Naltrexone"

Now showing items 1-7 of 7

    • Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone ... 
      Navarro, Montserrat; Carvajal, Francisca; Lerma Cabrera, José Manuel; Cubero, Inmaculada; Picker, Mitchell J.; Thiele, Todd E. (Blackwell, 2015)
      Background—The non-selective opioid receptor antagonist, naltrexone (NAL), reduces alcohol (ethanol) consumption in animals and humans and is an approved medication for treating alcohol abuse disorders. Proopiomelanocortin ...
    • Involvement of nitridergic and opioidergic pathways in the antinociception of gabapentin in the orofacial ... 
      Miranda, Hugo; Sierralta, Fernando; Lux, Sebastian; Troncoso, Rocío; Ciudad, Natalia; Zepeda Iriarte, Ramiro; Zanetta, Pilar; Noriega, Viviana; Prieto, Juan Carlos (Elsevier, 2015)
      Background: Pain is one of the most common problems in clinical medicine. There is considerable evidence that pharmacologic approaches are the most widely used therapeutic options to ameliorate persistent or chronic pain. ...
    • Naltrexone effects on insulin sensitivity and insulin secretion in hyperandrogenic women 
      Sir Petermann, Teresa; López, G.; Castillo, T.; Calvillán,; Rabenbauer, B.; Wildt, L. (1998)
      A total of 12 women (24.2 ± 1.6 years old, BMI 36.7 ± 1.5 Kg/m2) with hyperandrogenism (HA) and with normal glucose tolerance test were studied to evaluate the involvement of endogenous opioids in the pathophysiology of ...
    • Opiate antagonist treatment of ovarian failure 
      Wildt, L.; Sir Petermann, Teresa; Leyendecker, G.; Waibel-Treber, S.; Rabenbauer, B. (1993)
      One-hundred-and-thirty-eight women suffering from hypothalamicor hyperandrogenic ovarian failure were treatedwith daily doses of 25-150 mg of the opiate antagonist naltrexone for 4-100 weeks.In patients with hypothalamicovarian ...
    • Previous administration of naltrexone did not change synergism between paracetamol and tramadol in mice 
      Miranda, Hugo F.; Noriega, Viviana; Prieto, Juan Carlos (2012)
      In the treatment of acute and chronic pain the most frequently used drugs are nonsteroidal anti-inflammatory drugs (NSAIDs), e.g., paracetamol; opioids, e.g., tramadol, and a group of drugs called coanalgesics or adjuvants ...
    • Racemic salsolinol and its enantiomers act as agonists of the µ-opioid receptor by activating the Gi ... 
      Berríos Cárcamo, Pablo; Quintanilla González, María Elena; Herrera-Marschitz Muller, Mario; Vasiliou, Vasilis; Zapata Torres, Gerald; Rivera Meza, Mario (Frontiers Media S.A., 2017)
      © 2017 Berríos-Cárcamo, Quintanilla, Herrera-Marschitz, Vasiliou, Zapata-Torres and Rivera-Meza. Background: Several studies have shown that the ethanol-derived metabolite salsolinol (SAL) can activate the mesolimbic system, ...
    • Salsolinol, free of isosalsolinol, exerts ethanol-like motivational/sensitization effects leading to increases ... 
      Quintanilla González, María Elena; Rivera Meza, Mario; Berríos Cárcamo, Pablo; Bustamante, Diego; Buscaglia, Marianne; Morales, Paola; Karahanian, Eduardo; Herrera-Marschitz Muller, Mario; Israel Jacard, Yedy (Elsevier Inc., 2014)
      © 2014 Elsevier Inc.Salsolinol is formed non-enzymatically when ethanol-derived acetaldehyde binds to dopamine, yielding 2 distinct products, i.e., salsolinol and isosalsolinol. Early animal studies, revealing that salsolinol ...